These findings suggest that distinct CD4+ T cell populations and specific TCR signatures may serve as potential biomarkers for metabolic dysfunction in obesity, providing insights into immune mechanisms underlying the transition from MHO to MUO. The gene discussed is CD4; the disease is obesity due to melanocortin 4 receptor deficiency.